INVO Fertility Inc
7 hedge funds and large institutions have $195K invested in INVO Fertility Inc in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 0 reducing their positions, and 5 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
30% less funds holding
Funds holding: 10 → 7 (-3)
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
87% less capital invested
Capital invested by funds: $1.54M → $195K (-$1.35M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$9.69K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$9.69K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$882K |
| 2 |
IC
IEQ Capital
Foster City,
California
|
-$31.9K |
| 3 |
HighTower Advisors
Chicago,
Illinois
|
-$14K |
| 4 |
Jane Street
New York
|
-$12.7K |
| 5 |
HF
HRT Financial
New York
|
-$11K |
IVF Hedge Fund Activity: Q2 2023 in Review
7 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in INVO Fertility Inc (IVF) for Q2 2023, worth a combined $195K — down 87% from $1.54M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of IVF and 2 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $9.69K. The largest seller was Armistice Capital, exiting entirely with an estimated $882K sold.
- 7 institutional investors held INVO Fertility Inc (IVF) as of Q2 2023, down from 10 in Q1 2023.
- Funds reported $195K of INVO Fertility Inc stock for Q2 2023, down 87% quarter-over-quarter.
- 2 funds opened new INVO Fertility Inc positions in Q2 2023 and 5 closed out, a net change of -3 holders.
- The largest INVO Fertility Inc buyer in Q2 2023 was Renaissance Technologies, an estimated $9.69K added.
- The largest INVO Fertility Inc seller in Q2 2023 was Armistice Capital, an estimated $882K sold.
Based on aggregated 13F filings for Q2 2023.